Consistent with our observation that SREBP2 regulates expression of TP63 targets in human SCC cells (see Fig. S1e), we also observed a reduction in ΔNp63 positive nuclei in KPLS2 tumours (Fig. 6g, h). Here, TP63 is linked to neoplasm.